Ren Yu, Zhao Yong, Yang Xiangdong, Shen Chaojun, Luo Hua
Department of Pharmacy, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, Zhejiang, China.
Department of Orthopedics, Shanghai Fengxian District Central Hospital, Shanghai, China.
Front Med (Lausanne). 2023 Mar 8;10:1111371. doi: 10.3389/fmed.2023.1111371. eCollection 2023.
Aspirin is widely used in the primary and secondary prevention of cardiovascular and cerebrovascular diseases. Low-dose aspirin is also widely used to prevent pre-eclampsia and fetal growth retardation in utero. However, the use of aspirin during pregnancy is controversial. Since 1985, when aspirin was reported to be effective in obstetrics, numerous studies have attempted to determine the effect of low-dose aspirin on the morbidity of pre-eclampsia but have remained inconclusive. Guidelines for aspirin in preventing pre-eclampsia are different in different countries and regions. This article summarizes the research progress, mechanism, and application prospect of aspirin in preventing pre-eclampsia, providing a theoretical basis for the rational use of aspirin in pregnancy.
阿司匹林广泛应用于心脑血管疾病的一级和二级预防。低剂量阿司匹林还被广泛用于预防子痫前期和子宫内胎儿生长受限。然而,孕期使用阿司匹林存在争议。自1985年阿司匹林在产科被报道有效以来,众多研究试图确定低剂量阿司匹林对子痫前期发病率的影响,但仍无定论。不同国家和地区关于阿司匹林预防子痫前期的指南各不相同。本文总结了阿司匹林预防子痫前期的研究进展、作用机制及应用前景,为孕期合理使用阿司匹林提供理论依据。